William Blair & Company
PYXS icon

William Blair & Company’s Pyxis Oncology PYXS Stock Holding History

William Blair & Company’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,000
Closed -$36.7K – 1870
2024
Q3 		$36.7K Hold
10,000
– – ﹤0.01% 1665
2024
Q2 		$33.1K Sell
10,000
-100
-1% -$420 ﹤0.01% 1646
2024
Q1 		$43K Buy
+10,100
New +$42.5K ﹤0.01% 1615

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

William Blair & Company's PYXS Position: Q4 2024 in Review

William Blair & Company sold out of Pyxis Oncology (PYXS) in Q4 2024, closing a stake of 10,000 shares — an estimated $36.7K sold.

William Blair & Company first reported a position in PYXS in Q1 2024 and held it in 3 quarters. The position peaked at $43K in Q1 2024. 99 funds tracked by Wall St. Rank hold PYXS as of Q4 2024.

  • William Blair & Company reported no remaining Pyxis Oncology position as of Q4 2024 after selling out during the quarter.
  • William Blair & Company sold 10,000 Pyxis Oncology shares in Q4 2024, an estimated $36.7K.
  • William Blair & Company first reported a position in Pyxis Oncology in Q1 2024 and held it in 3 quarters.
  • William Blair & Company's Pyxis Oncology position peaked at $43K in Q1 2024.
  • 99 funds tracked by Wall St. Rank held Pyxis Oncology as of Q4 2024.

Based on William Blair & Company's 13F filing for Q4 2024, filed 12 Feb 2025.